BETA(2)-MICROGLOBULIN DEPENDENCE OF THE LUPUS-LIKE AUTOIMMUNE SYNDROME OF MRL-LPR MICE

Citation
Gj. Christianson et al., BETA(2)-MICROGLOBULIN DEPENDENCE OF THE LUPUS-LIKE AUTOIMMUNE SYNDROME OF MRL-LPR MICE, The Journal of immunology, 156(12), 1996, pp. 4932-4939
Citations number
53
Categorie Soggetti
Immunology
Journal title
The Journal of immunology
ISSN journal
00221767 → ACNP
Volume
156
Issue
12
Year of publication
1996
Pages
4932 - 4939
Database
ISI
SICI code
0022-1767(1996)156:12<4932:BDOTLA>2.0.ZU;2-N
Abstract
MRL-lpr/lpr mice develop a distinctive immunologic disease characteriz ed by accumulation of unusually large numbers of T cells in the periph eral lymphoid organs. Most of the accumulating T cells express an alph a beta-TCR but are peculiar in that they express neither CD4 nor CD8 c o-ligands. Concurrent with lymphoaccumulation of such double negative (DN) T cells, MRL-lpr/lpr mice develop a lethal systemic lupus erythem atosus-like autoimmune syndrome. This study focuses on the role of MHC class I molecules in this latter pathologic process. Highly backcross ed class I molecule-deficient MRL and MRL-lpr mice carrying a function ally defective allele of the gene beta(2)-microglobulin (B2m) were pro duced. Class I-deficient MRL-lpr/lpr mice demonstrated a substantial r eduction in DN T cells, confirming other reports indicating that most DN T cells arise from progenitors positively selected on MHC class I m olecules. Significantly, class I-deficient MRL-lpr/lpr mice also demon strated a diminution of every autoimmune disease indicator analyzed in cluding hypergammaglobulinemia; autoantibodies including anti-DNA, ant i-Smith antigen, and rheumatoid factor; and glomerulonephritis. The re sults indicate that class I-dependent T cells are crucial not only for the development of DN T cells, but for multiple features of the MRL-l pr/lpr systemic lupus erythematosus syndrome. Moreover, the pattern of hypergammaglobulinemia suggests that the requirement for MHC class I proteins is restricted temporally to later stages of the disease.